Press release
Intratumoral Cancer Therapies Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Intratumoral Cancer Therapies Market Size
The rise in cancer cases is anticipated to boost the expansion of the intratumoral cancer therapies market in the future. Cancer refers to a variety of diseases characterized by uncontrolled growth and spread of abnormal cells within the body. Intratumoral cancer therapies aid in the diagnosis and treatment of cancer, helping to prevent off-target toxicities, dose-limiting toxicities, and negative side effects caused by immune stimulation in cancer patients. For example, the American Cancer Society, a non-profit cancer advocacy organization based in the United States, reported an increase in the number of cancer cases to 1,958,310 in January 2023, up 3.16% from 1,898,160 in 2021. Hence, the rising prevalence of cancer is contributing to the growth of the intratumoral cancer therapies market.
Get Your Intratumoral Cancer Therapies Market Report Here:
https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report
What is the future CAGR of the intratumoral cancer therapies market, and how will it impact industry expansion?
The market size for intratumoral cancer treatments has seen a considerable expansion in the past few years. The market's value is projected to increase from $140 billion in 2024 to $158.38 billion in 2025, with a compound annual growth rate (CAGR) of 13.1%. The significant growth observed in the past can be attributed to numerous factors, including advancements in cancer research, a rise in cancer cases, an increased demand for precision medicine, substantial clinical evidence, research initiatives, and unresolved medical needs.
The market size of intratumoral cancer treatments is anticipated to undergo swift expansion in the coming years, with forecasts predicting a rise to $248.42 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 11.9%. The driving factors behind this expected growth during the forecast period include advancements in immunotherapy, a heightened use of precision medicine, expansion of clinical trials, increased attention towards rare cancers, and supportive regulatory measures and approvals. The forecast period also sees key trends such as the research on intratumoral immunomodulators, incorporating image-guided treatments, the use of hyperthermia in intratumoral therapies, clinical trials examining combination therapies, and regulatory assistance for intratumoral therapies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9979&type=smp
What are the most significant trends transforming the intratumoral cancer therapies market today?
Technology advances are becoming a significant trend in the intratumoral cancer therapies market. To maintain their market dominance, businesses in this sector are embracing new technologies. For instance, Evonik, a US specialty chemical manufacturer, unveiled EUDRATEC SoluFlow, an innovative microparticle technology, in March 2022. This technology, geared towards enhancing the solubility of active pharmaceutical constituents in oral medication formulations, is set to revolutionize cancer therapies. Leveraging this ground-breaking technology, chemicals once deemed insoluble can now be included in a broader range of oral medications.
Which key market segments comprise the intratumoral cancer therapies market and drive its revenue growth?
The intratumoral cancer therapies market covered in this report is segmented -
1) By Technology: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines
2) By Application: Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head And Neck Cancer, Other Applications
3) By End Users: Hospitals, Cancer Research Centers, Clinics
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
3) By Checkpoint Inhibitors: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Cell Therapies: CAR T-Cell Therapy, TCR Therapy
5) By Immune System Modulators: Immune Checkpoint Inhibitors, Toll-Like Receptor Agonists
6) By Adoptive Cell Transfer: Tumor-Infiltrating Lymphocytes (TILs), Peripheral Blood Lymphocytes (PBLs)
7) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factor (TNF)
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9979
What regions are at the forefront of intratumoral cancer therapies market expansion?
North America was the largest region in the intratumoral cancer therapies market in 2024. The regions covered in the intratumoral cancer therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the leading players fueling growth in the intratumoral cancer therapies market?
Major companies operating in the intratumoral cancer therapies market include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc., Novartis AG, Johnson & Johnson, Eli Lilly and Company, F. Hoffmann-la Roche, Takeda Pharmaceutical Company Ltd., GSK plc, Ziopharm Oncology Inc., Celldex Therapeutics Inc., Astellas Pharma Inc., Sirnaomics, Checkmate Pharmaceuticals Inc., Immunovative Therapies Ltd., Idera Pharmaceuticals Inc., Daiichi Sankyo, Philogen S.p.A., Apexigen Inc., Merck Group, OncoSec Medical Incorporated, DNAtrix, Istari Oncology Inc., Nanobiotix, Exicure Inc., Karyopharm Therapeutics Inc., Dechra Pharmaceuticals PLC, Torigen Pharmaceuticals Inc., Elekta, Virbac, Norbrook Laboratories, Regeneus Ltd., QBiotics Group, VetDC
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9979&type=smp
What Is Covered In The Intratumoral Cancer Therapies Global Market Report?
• Market Size Forecast: Examine the intratumoral cancer therapies market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the intratumoral cancer therapies market for a structured understanding.
• Key Players Overview: Analyze major players in the intratumoral cancer therapies market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the intratumoral cancer therapies market.
• Segment Contributions: Evaluate how different segments drive overall growth in the intratumoral cancer therapies market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the intratumoral cancer therapies market.
• Industry Challenges: Identify potential risks and obstacles affecting the intratumoral cancer therapies market.
• Competitive Landscape: Review strategic developments in the intratumoral cancer therapies market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intratumoral Cancer Therapies Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3892195 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
